SC
BMY icon

Sawyer & Company’s Bristol-Myers Squibb BMY Stock Holding History

Sawyer & Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-300
Closed -$16.2K – 198
2025
Q4 		$16.2K Buy
+300
New +$14.4K 0.01% 146
2023
Q2 		– Sell
-165
Closed -$12K – 172
2023
Q1 		$12K Hold
165
– – 0.01% 152
2022
Q4 		$12K Hold
165
– – 0.01% 161
2022
Q3 		$12K Sell
165
-100
-38% -$7.25K 0.01% 154
2022
Q2 		$20K Sell
265
-135
-34% -$10.3K 0.01% 147
2022
Q1 		$29K Hold
400
– – 0.01% 143
2021
Q4 		$25K Hold
400
– – 0.01% 146
2021
Q3 		$24K Hold
400
– – 0.01% 145
2021
Q2 		$27K Sell
400
-400
-50% -$26.1K 0.01% 138
2021
Q1 		$51K Buy
+800
New +$49.8K 0.03% 121

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sawyer & Company's BMY Position: Q1 2026 in Review

Sawyer & Company sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 300 shares — an estimated $16.2K sold.

Sawyer & Company first reported a position in BMY in Q1 2021 and held it in 10 quarters. The position peaked at $51K in Q1 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Sawyer & Company reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Sawyer & Company sold 300 Bristol-Myers Squibb shares in Q1 2026, an estimated $16.2K.
  • Sawyer & Company first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 10 quarters.
  • Sawyer & Company's Bristol-Myers Squibb position peaked at $51K in Q1 2021.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Sawyer & Company's 13F filing for Q1 2026, filed 23 Apr 2026.